composto de piridazina, composições e métodos

• Main Authors: MAGDELENA ZASADZKI, D. MARTIN WATTERSON, JACQUES HAIECH, ANASTASIA VELENTZA, MARCEL HIBERT, WENHUI HU, LINDA VAN ELDIK, JEAN-JACQUES BOURGUIGNON
• Format: Patent
• Language: Portuguese
• Published: 21.10.2008
• Subjects: AGRICULTURE; ANIMAL HUSBANDRY; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; CHEMISTRY; FISHING; FORESTRY; HETEROCYCLIC COMPOUNDS; HUMAN NECESSITIES; HUNTING; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; ORGANIC CHEMISTRY; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF; TRAPPING

COMPOSTOS DE PIRIDAZINA, COMPOSIçõES E MéTODOS. A invenção relaciona-se a novos compostos químicos, composições e métodos de fazer e usar os mesmos. Em particular, a invenção fornece compostos de piridazina e/ou derivados heterocíclicos relacionados, composições que compreendem os mesmos, e métodos de fazer e usar os compostos de piridazina e/ou derivados heterocíclicos relacionados e composições que compreende os mesmos, para modulação das vias celulares (por exemplo, vias de transduçáo de sinal), para o tratamento ou prevenção de doenças inflamatórias (por exemplo, doença de Alzheimer), para pesquisa, rastreamento de medicamento, e aplicações terapêuticas. The invention relates to novel chemical compounds, compositions and methods of making and using the same. In particular, the invention provides pyridazine compounds and/or related heterocyclic derivatives, compositions comprising the same, and methods of making and using pyridazine compounds and/or related heterocyclic derivatives and compositions comprising the same, for modulation of cellular pathways (e.g., signal transduction pathways), for treatment or prevention of inflammatory diseases (e.g., Alzheimer's disease), for research, drug screening, and therapeutic applications. Compounds of Formula Ia or Ib or wherein R is a substituted amino group, R 2 is an unsaturated 5 to 6-membered heteromonocyclic group containing 1 to 4 nitrogen atoms, R 3 , R 4 , R 5 , and R 6 are hydrogen, and R 7 is absent; or a pharmaceutically acceptable salt thereof.